Bristol James Arthur
Insider CIK 1715153 · DCPH Director · ERAS Director · ERNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ERNA Ernexa Therapeutics Inc. | A Award deriv | 2026-08-31 | 2026-09-01 | 5,083 | — | $0 | 5,083 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | A Award deriv | 2026-08-31 | 2026-09-01 | 8,320 | — | $0 | 8,320 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | A Award deriv | 2026-08-31 | 2026-09-01 | 5,083 | — | $0 | 5,083 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | A Award deriv | 2026-08-31 | 2026-09-01 | 8,320 | — | $0 | 8,320 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2026-06-26 | 2026-06-29 | 29,888 | — | $0 | 29,888 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2026-01-01 | 2026-01-05 | 37,762 | — | $0 | 37,762 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | A Award deriv | 2025-02-07 | 2025-02-10 | 72,074 | — | $0 | 72,074 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2025-01-01 | 2025-01-02 | 45,678 | — | $0 | 45,678 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 12,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 18,500 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 9,570 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 30,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 67,494 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 22,150 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | A Award deriv | 2024-04-26 | 2024-04-29 | 124,525 | — | $0 | 124,525 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 62,747 | — | $0 | 62,747 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ERAS Erasca, Inc. | P Buy | 2022-12-21 | 2022-12-22 | 20,000 | $4.14 | $82.8K | 20,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2021-04-20 | 2021-04-21 | 1,700 | — | $0 | 22,150 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-04-20 | 2021-04-21 | 1,700 | $45.60 | $77.5K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2021-04-20 | 2021-04-21 | 1,700 | $3.95 | $6.7K | 1,700 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2021-04-19 | 2021-04-21 | 5,300 | — | $0 | 23,850 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2021-04-19 | 2021-04-21 | 5,300 | $3.95 | $20.9K | 5,300 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-04-19 | 2021-04-21 | 4,000 | $46.13 | $184.5K | 1,300 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-04-19 | 2021-04-21 | 1,300 | $46.66 | $60.7K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2021-04-12 | 2021-04-14 | 14,700 | — | $0 | 29,150 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-04-12 | 2021-04-14 | 5,217 | $44.09 | $230.0K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2021-04-12 | 2021-04-14 | 14,700 | $3.95 | $58.1K | 14,700 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-04-12 | 2021-04-14 | 9,483 | $43.70 | $414.4K | 5,217 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2021-01-15 | 2021-01-20 | 7,000 | — | $0 | 43,850 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2021-01-15 | 2021-01-20 | 7,000 | $3.95 | $27.6K | 7,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-01-15 | 2021-01-20 | 600 | $51.11 | $30.7K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-01-15 | 2021-01-20 | 6,400 | $50.21 | $321.3K | 600 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-10-09 | 2020-10-13 | 23,541 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-10-09 | 2020-10-13 | 200 | $55.43 | $11.1K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-10-09 | 2020-10-13 | 3,971 | $54.53 | $216.5K | 200 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-10-09 | 2020-10-13 | 23,541 | $1.89 | $44.5K | 23,541 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-10-09 | 2020-10-13 | 19,370 | $53.35 | $1.03M | 4,171 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-07-09 | 2020-07-13 | 7,217 | — | $0 | 23,541 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-07-09 | 2020-07-13 | 16,324 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-07-09 | 2020-07-13 | 12,361 | $54.65 | $675.5K | 11,180 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-07-09 | 2020-07-13 | 7,217 | $1.89 | $13.6K | 23,541 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-07-09 | 2020-07-13 | 16,324 | $1.89 | $30.9K | 16,324 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-07-09 | 2020-07-13 | 301 | $57.02 | $17.2K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-07-09 | 2020-07-13 | 1,829 | $56.24 | $102.9K | 301 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-07-09 | 2020-07-13 | 9,050 | $55.15 | $499.1K | 2,130 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-04-09 | 2020-04-13 | 23,542 | — | $0 | 16,324 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-04-09 | 2020-04-13 | 6,373 | $42.97 | $273.8K | 17,169 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-04-09 | 2020-04-13 | 11,012 | $44.18 | $486.5K | 536 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-04-09 | 2020-04-13 | 536 | $45.88 | $24.6K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-04-09 | 2020-04-13 | 23,542 | $1.89 | $44.5K | 23,542 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-04-09 | 2020-04-13 | 5,621 | $43.93 | $246.9K | 11,548 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-01-03 | 2020-01-06 | 7,989 | — | $0 | 39,866 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-03 | 2020-01-06 | 1,810 | $58.17 | $105.3K | 200 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-03 | 2020-01-06 | 5,250 | $57.21 | $300.4K | 2,010 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-03 | 2020-01-06 | 729 | $55.96 | $40.8K | 7,260 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-01-03 | 2020-01-06 | 7,989 | $1.89 | $15.1K | 7,989 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-03 | 2020-01-06 | 200 | $58.72 | $11.7K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-01-02 | 2020-01-06 | 15,553 | — | $0 | 47,855 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-02 | 2020-01-06 | 300 | $61.87 | $18.6K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-02 | 2020-01-06 | 365 | $59.38 | $21.7K | 300 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-02 | 2020-01-06 | 5,347 | $58.08 | $310.6K | 665 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-02 | 2020-01-06 | 9,541 | $57.51 | $548.7K | 6,012 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-01-02 | 2020-01-06 | 15,553 | $1.89 | $29.4K | 15,553 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-11-01 | 2019-11-05 | 25,000 | — | $0 | 63,408 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-11-01 | 2019-11-05 | 25,000 | $1.89 | $47.3K | 25,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-11-01 | 2019-11-05 | 25,000 | $45.07 | $1.13M | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-08-13 | 2019-08-13 | 25,000 | — | $0 | 88,408 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-13 | 2019-08-13 | 700 | $42.05 | $29.4K | 100 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-13 | 2019-08-13 | 100 | $42.90 | $4.3K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-08-13 | 2019-08-13 | 25,000 | $1.89 | $47.3K | 25,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-13 | 2019-08-13 | 11,513 | $39.24 | $451.8K | 13,487 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-13 | 2019-08-13 | 12,687 | $40.50 | $513.8K | 800 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-06-11 | 2019-06-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-02-15 | 2019-02-19 | 17,782 | — | $0 | 113,408 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-02-15 | 2019-02-19 | 17,782 | $1.89 | $33.6K | 17,782 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-02-15 | 2019-02-19 | 17,782 | $28.04 | $498.6K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-02-14 | 2019-02-19 | 1,101 | — | $0 | 131,190 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-02-14 | 2019-02-19 | 1,101 | $28.01 | $30.8K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-02-14 | 2019-02-19 | 1,101 | $1.89 | $2.1K | 1,101 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-02-13 | 2019-02-14 | 2,922 | — | $0 | 132,291 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-02-13 | 2019-02-14 | 2,922 | $28.01 | $81.8K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-02-13 | 2019-02-14 | 2,922 | $1.89 | $5.5K | 2,922 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-02-12 | 2019-02-14 | 600 | — | $0 | 135,213 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-02-12 | 2019-02-14 | 600 | $28.00 | $16.8K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-02-12 | 2019-02-14 | 600 | $1.89 | $1.1K | 600 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2019-02-05 | 2019-02-07 | 2,595 | — | $0 | 135,813 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2019-02-05 | 2019-02-07 | 2,595 | $1.89 | $4.9K | 2,595 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-02-05 | 2019-02-07 | 2,595 | $28.02 | $72.7K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2018-05-17 | 2018-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 30,758 | — | $0 | 30,758 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 9,000 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 5,444 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 138,408 | — | $0 | 138,408 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 24,497 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 67,494 | — | $0 | 67,494 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 11,946 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 50,850 | — | $0 | 50,580 | SEC↗ |